References
1. Czeisler MÉ, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19–related concerns—United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250-1257. doi:10.15585/mmwr.mm6936a4
2. National Cancer Institute’s PROSPR Consortium; Corley DA, Sedki M, et al. Cancer screening during the Coronavirus Disease-2019 pandemic: a perspective from the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2020;S0016-5085(20)35317-8. doi: 10.1053/j.gastro.2020.10.030
3. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281. doi:10.3322/caac.21457
4. Kaufman HW, Chen Z, Niles J, et al. Changes in the number of US patients with newly identified cancer before and during the Coronavirus Disease 2019 (COVID-19) pandemic. JAMA Netw Open. 2020;3(8):e2017267. doi:10.1001/jamanetworkopen.2020.17267
5. Cheng SY, Chen CF, He HC, et al. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy. J Gastroenterol Hepatol. 2020;10.1111/jgh.15325. doi: 10.1111/jgh.15325
6. Patel S, Lorenzi N, Smith T, et al. Critical insights from patients during the COVID-19 pandemic. NEJM Catalyst. 2020. doi:10.1056/CAT.20.0299
7. Cancer screening during the COVID-19 pandemic. American Cancer Society. Revised July 2, 2020. Accessed January 13, 2021. https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/cancer-screening-during-covid-19-pandemic.html
8. Shaukat A, Church T. Colorectal cancer screening in the USA in the wake of COVID-19. Lancet Gastroenterol Hepatol. 2020;5(8):726-727. doi: 10.1016/S2468-1253(20)30191-6
9. American Cancer Society. Cancer Facts & Figures. American Cancer Society; 2020. Accessed January 13, 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
10. Hadjipetrou A, Anyfantakis D, Galanakis CG, et al. Colorectal cancer, screening and primary care: a mini literature review. World J Gastroenterol. 2017;23(33):6049-6058. doi:10.3748/wjg.v23.i33.6049
11. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Gastroenterology. 2017;153(1):307-323. doi:10.1053/j.gastro.2017.05.013
12. Cancer stat facts: colorectal cancer. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Accessed January 13, 2021. https://seer.cancer.gov/statfacts/html/colorect.html
13. Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018;67(2):291-298. doi:10.1136/gutjnl-2016-312712
14. Recio-Boiles A, Cagir B. Colon cancer. In: StatPearls [Internet]. StatPearls Publishing; 2020. Updated August 10, 2020. Accessed January 13, 2021. https://www.ncbi.nlm.nih.gov/books/NBK470380/
15. Balzora S, Issaka RB, Anyane-Yeboa A, et al. Impact of COVID-19 on colorectal cancer disparities and the way forward. Gastrointest Endosc. 2020;92(4):946-950. doi:10.1016/j.gie.2020.06.042
16. Mitchell EP. Declines in cancer screening during COVID-19 pandemic. J Natl Med Assoc. 2020;112(6):563-564. doi:10.1016/j.jnma.2020.12.004
17. London JW, Fazio-Eynullayeva E, Palchuk MB, et al. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Inform. 2020;4:657-665. doi:10.1200/CCI.20.00068
18. Nodora JN, Gupta S, Howard N, et al. The COVID-19 pandemic: identifying adaptive solutions for colorectal cancer screening in underserved communities. J Natl Cancer Inst. 2020;djaa117. doi:10.1093/jnci/djaa117
19. Vecchione L, Stintzing S, Pentheroudakis G, et al. ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer. ESMO Open. 2020;5(suppl 3):e000826. doi:10.1136/esmoopen-2020-000826
20. Ladabaum U, Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia. Gastroenterology. 2016;151(3):427-439.e6. doi:10.1053/j.gastro.2016.06.003.
Models used for illustrative purposes only.
Published date: Mar 2021